Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.48 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.48 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.43 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.43 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.43 |
| ▸ | MMP2 | P08253 | 2/20 | 0.43 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | RAD52 | P43351 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4590790 | 1.00 | GPR84 (0.50) | GPR84FFAR1FFAR4SPHK1PSMD14 | |
| SCHEMBL28337820 | 1.00 | GPR84 (0.50) | GPR84FFAR1FFAR4SPHK1PSMD14 | |
| SCHEMBL2833193 | 1.00 | GPR84 (0.50) | GPR84FFAR1FFAR4SPHK1PSMD14 | |
| SCHEMBL2837110 | 1.00 | GPR84 (0.50) | GPR84FFAR1FFAR4SPHK1PSMD14 | |
| SCHEMBL6554066 | 1.00 | GPR84 (0.50) | GPR84FFAR1FFAR4SPHK1PSMD14 | |
| SCHEMBL6552497 | 1.00 | GPR84 (0.50) | GPR84FFAR1FFAR4SPHK1PSMD14 | |
| SCHEMBL1728942 | 1.00 | GPR84 (0.50) | GPR84FFAR1FFAR4SPHK1PSMD14 | |
| SCHEMBL1407661 | 1.00 | GPR84 (0.50) | GPR84FFAR1FFAR4SPHK1PSMD14 | |
| Hydrochloric Acid SCHEMBL7902387 | 0.98 | GPR84 (0.48) | GPR84FFAR1FFAR4SPHK1PSMD14 | |
| Hydrochloric Acid SCHEMBL21835998 | 0.98 | GPR84 (0.48) | GPR84FFAR1FFAR4SPHK1PSMD14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1934234-B1 | NOVEL AMINE-BORANE COMPOUNDS AND USES THEREOF | YISSUM RES DEV CO (IL) | 2011-11-30 | — | — | EP | claimed |
| US-20090131366-A1 | Use of Amine-Borane Compounds as Anti-Microbial Agents | HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD. (IL) | 2009-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090131366-A1 | Use of Amine-Borane Compounds as Anti-Microbial Agents | BCAT2, BCAT1, ARG1 | GPR84 569/4885FFAR1 964/4885FFAR4 2967/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.